Mmbg Investment Advisors CO. Invests $4.12 Million in Danaher Corporation $DHR

Mmbg Investment Advisors CO. acquired a new position in Danaher Corporation (NYSE:DHRFree Report) during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund acquired 21,570 shares of the conglomerate’s stock, valued at approximately $4,117,000.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in DHR. West Family Investments Inc. acquired a new stake in shares of Danaher in the second quarter valued at about $230,000. Bantamac Capital LLC purchased a new stake in shares of Danaher in the second quarter valued at approximately $762,000. Knuff & Co LLC acquired a new stake in shares of Danaher in the second quarter valued at approximately $1,231,000. NewEdge Wealth LLC acquired a new position in Danaher during the second quarter worth $1,879,000. Finally, Generation Investment Management LLP acquired a new stake in shares of Danaher in the 2nd quarter worth $1,287,949,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Danaher Stock Performance

Shares of DHR opened at $211.92 on Thursday. The company’s 50 day simple moving average is $194.30 and its 200-day simple moving average is $192.44. The firm has a market cap of $148.98 billion, a PE ratio of 37.64, a price-to-earnings-growth ratio of 2.49 and a beta of 0.78. Danaher Corporation has a 12-month low of $160.93 and a 12-month high of $242.80. The company has a current ratio of 1.65, a quick ratio of 1.25 and a debt-to-equity ratio of 0.48.

Danaher (NYSE:DHRGet Free Report) last released its quarterly earnings results on Monday, July 20th. The conglomerate reported $1.94 EPS for the quarter, beating the consensus estimate of $1.85 by $0.09. The firm had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. Danaher’s revenue for the quarter was up 5.5% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.77 EPS. As a group, equities analysts predict that Danaher Corporation will post 8.53 EPS for the current year.

Wall Street Analyst Weigh In

Several analysts have recently commented on DHR shares. Morgan Stanley reduced their price target on shares of Danaher from $270.00 to $255.00 and set an “overweight” rating on the stock in a research report on Wednesday, April 22nd. Wall Street Zen lowered shares of Danaher from a “buy” rating to a “hold” rating in a report on Saturday, April 25th. JPMorgan Chase & Co. decreased their price objective on Danaher from $275.00 to $245.00 and set an “overweight” rating for the company in a research note on Wednesday, April 22nd. HSBC cut their price target on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a research note on Wednesday, June 3rd. Finally, Deutsche Bank Aktiengesellschaft reaffirmed a “buy” rating and issued a $240.00 price target on shares of Danaher in a report on Wednesday, July 22nd. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $228.91.

Check Out Our Latest Stock Analysis on DHR

Danaher Profile

(Free Report)

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Featured Stories

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.